Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease
  2. Li, M.; Gustchina, A.; Matuz, K.; Tozser, J.; Namwong, S.; Goldfarb, N. E.; Dunn, B. M.; Wlodawer, A.
  3. Febs Journal. 2011, Nov; 278(22): 4413-4424.
  1. 2.   The Early Years of Retroviral Protease Crystal Structures
  2. Miller, M.
  3. Biopolymers. 2010 94(4): 521-529.
  1. 3.   Action of Anti-HIV drugs and resistance: Reverse transcriptase inhibitors and protease inhibitors
  2. Imamichi, T.
  3. Current Pharmaceutical Design. 2004 10(32): 4039-4053.
  1. 4.   Proteolytic events of HIV-1 replication as targets for therapeutic intervention
  2. Tozser, J.; Oroszlan, S.
  3. Current Pharmaceutical Design. 2003 9(22): 1803-1815.
  1. 5.   Reverse transcriptase and protease sequence evolution in two HIV-1-infected couples
  2. Palmer, S.; Vuitton, D.; Gonzales, M. J.; Bassignot, A.; Shafer, R. W.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2002 31(3): 285-290.
  1. 6.   Rational approach to AIDS drug design through structural biology
  2. Wlodawer, A.
  3. Annual Review of Medicine. 2002 53: 595-614.
  1. 7.   HIV protease: Enzyme function and drug resistance
  2. Gulnik, S.; Erickson, J. W.; Xie, D.
  3. Vitamins and Hormones - Advances in Research and Applications, Vol 58. 2000 58: 213-256.
  1. 8.   Structural and biochemical studies of retroviral proteases
  2. Wlodawer, A.; Gustchina, A.
  3. Biochimica et Biophysica Acta - Protein Structure & Molecular Enzymology. 2000 1477(1-2): 16-34.
  1. 9.   Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy
  2. Nijhuis, M.; Schuurman, R.; de Jong, D.; Erickson, J.; Gustchina, E.; Albert, J.; Schipper, P.; Gulnik, S.; Boucher, C. A. B.
  3. Aids. 1999 13(17): 2349-2359.
  1. 10.   Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies
  2. Erickson, J. W.; Gulnik, S. V.; Markowitz, M.
  3. Aids. 1999 13(Suppl A): S189-S204.
  1. 11.   Calculation of Relative Binding Free Energies of Peptidic Inhibitors to Hiv-1 Protease and Its I84v Mutant
  2. Tawa, G. J.; Topol, I. A.; Burt, S. K.; Erickson, J. W.
  3. Journal of the American Chemical Society. 1998 120(34): 8856-8863.
  1. 12.   Inhibitors of Hiv-1 Protease - a Major Success of Structure-Assisted Drug Design
  2. Wlodawer, A.; Vondrasek, J.
  3. Annual Review of Biophysics and Biomolecular Structure. 1998 27: 249-284.
  1. 13.   Crystal Structures of the Inactive D30n Mutant of Feline Immunodeficiency Virus Protease Complexed With a Substrate and an Inhibitor
  2. Laco, G. S.; Schalkhihi, C.; Lubkowski, J.; Morris, G.; Zdanov, A.; Olson, A.; Elder, J. H.; Wlodawer, A.; Gustchina, A.
  3. Biochemistry. 1997 36(35): 10696-10708.
  1. 14.   Analysis of the Structure of Chemically Synthesized Hiv-1 Protease Complexed With a Hexapeptide Inhibitor .1. Crystallographic Refinement of 2 Angstrom Data
  2. Miller, M.; Geller, M.; Gribskov, M.; Kent, S. B. H.
  3. Proteins. 1997 27(2): 184-194.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel